Chronic Bronchiolitis or Resistant Asthma?
Information source: Baqiyatallah Medical Sciences University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Asthma
Intervention: Erythromycin, Azithromycin , Clarithromycin (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: Baqiyatallah Medical Sciences University Official(s) and/or principal investigator(s):
Mostafa Ghanei, Prof, Principal Investigator, Affiliation: Research Center of Chemical Injuries, Baqyatallah Medical Sciences University, Tehran, Iran
Summary
Chronic Bronchiolitis or Resistant Asthma? Testing a way to diagnosis and treatment
Clinical Details
Study design: Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Difficult asthma
Exclusion Criteria:
- Patients with potential allergic bronchopulmonary aspergillosis i. e. with peripheral
blood eosinophilia, sputum eosinophilia, or any sputum production and bronchiectasis
- A history of smoking
- Significant occupational or environmental exposures
- Evidence on emphysema on chest high resolution computed tomography (HRCT) scan
Locations and Contacts
Additional Information
Last updated: February 17, 2009
|
